JSC “Grindeks” informs, that based on decision of JSC “Grindeks” council, Andrejs Liberts has been appointed as the member of JSC “Grindeks” board. A.Liberts was born in 1985, he has proven himself in ...

JSC „Grindeks" informs on its investment of 1.6 million lats in the Quality control laboratory, out of which 1.33 million lats will be invested in the construction, but more than 270 thousand lats – ...

JSC “Grindeks” announces an update to its corporate brand, including refreshed logo, custom typeface and style. To assure the visual sustainability, “Grindeks” proudly presents the novelty – Grindelia ...

Grindeks is a prequalified supplier for the World Health Organization, supplying its manufactured injections to international organizations such as UNFPA and UNICEF. These organizations distribute the ...

RIGA, Latvia, Nov. 8, 2021 /PRNewswire/ -- The consolidated, provisional financial data of "Grindeks" Group shows that in the first nine months of 2021 the Group has reached record high turnover and ...

Turnover of "Grindeks" reaches 132.4 million euro in 2017; profit - 10.3 million euro Today, on 28 February, the JSC "Grindeks" submitted the non-audited consolidated financial statements of 2017 to ...

The leading pharmaceutical manufacturer in the Baltic region, Grindeks, which has been operating on the Georgian market for sixteen years, will offer the latest generation of anti-diabetic drugs to ...

RIGA, Latvia, Aug. 16, 2021 /PRNewswire/ -- The consolidated, provisional financial data of "Grindeks" Group shows that in the first half of 2021 the Group has reached record high turnover and profit.